Treated With Gestajen in Endometrial Hyperplazi

[Endometrial Hyperplazi'de Gestagen Tedavisi]


Abstract views: 28 / PDF downloads: 51

Authors

  • Halil SAYGILI İstanbul Üniversitesi Tıp Fakültesi Kadın Hast.ve Doğum ABD.Uzm.Dr .
  • Recep HAS İstanbul Üniversitesi Tıp Fakültesi Kadın Hast.ve Doğum ABD.Asis.Dr.
  • Alkan YILDIRIM İstanbul Üniversitesi Tıp Fakültesi Kadın Hast.ve Doğum ABD.Uzm.Dr .

DOI:

https://doi.org/10.58600/eurjther.19920302-1067

Keywords:

Noretisteron, Lynestnenot, Endometrial Hyperplasia

Abstract

88 patient which have abnormal uterin bleeding in premenopausal period treated with lynestrenol or noretisteron, 18 of 75 cases which had cystic glanduler hyperplasia hystologically, treated with norethisteron, other 57 with lynestrenol and 9 cases which had adenomatous-hyperplasia and cases which had atypic glanduler hyperplasia all treated with lynestrenol, 3 months after with treatment norethisteron in 13 of 18 patient hystological improvement find out (% 72.2) and in 5 of them because the same patology remained, hysterectomy performed:20 of 57 patients (% 35.0) treated for cystic glanduler hyperplasia, and 3 of 9 patients treated for adenomatous hyperplasia are found improved at control FC aftear 3 months. 22 cases (include 6 ademomatous and 4 atypic hyperplasia went to hysterectomy. Another treatment is given to remained 25 cystic glanduler hyperplasia cases for three months and 6 of them improved, 6 went to hysterectomy. To the patients whom histological findings not changed are given lynestrenol again months, and 7 improved 6 did not, so performed hysterectomy. Thus, while 13 of the 18 patients who are given N.E. are improved (% 72.2), only 36 of 70 patients given lynestrenol are hystologically recoverid. (% 51.4) The difference between two groups are found istatistically significant (p 0.05).As a result, it is concluded that N.E. is more effective than lynestrenol.

Metrics

Metrics Loading ...

References

(1).Beutler, H.K.Dockerty M.B.Randal L.M:Precancerous lesions of the endometrium. Am.J.Obs. Gyn.86:433(1963).

(2). Chamblion D.L, Taylor H.B.Endometrial hyperplasia in young women.Obs.Gyn. 36:659- 666(1970).

- (8).Eichner, E.Abellera,M:Endometrial hyperplasia treated by progestins.Obs.Gyn.38:739(1971).

- (9).Fritz M.A.Speroff L:The role of progestational agents in hormone replacement therapy. İn the menopause, Hersg. von Buchbau H.J.5pringer Verlag Berlin, Heidelberg. Newyork. 85-100(1983).

- (10).Gal D.Edman, CD.Vellios F.Fomey.J.P:Long term effect of megestrol acetate in the treatrnent of endometrial hyperplasia.Am.J.Obs.Gyn.46:316(1983).

- (11).Gambrell, RD:The menopause, benefits and rists of estrogen-progesteron therapy.Fer.5teril 37:457(1982)

- (3).Gusberg 5.B, Kaplan A:Precursors of corpus cancer. Adenomatous hyperplasia as stage o carcinoma of the vendometrium. Am.J.Obs.Gyn.87:662(1963)

- (7).Kistner RW:The effects of progestational agents on hyperplasia and carcinoma in situ of the endometrium. İnt. J. Gyn. Obs. 8:561(1970)

- (6).5harpio 55, Ayer RA, Colas AE:5ynthetic progestins in vitro potency on human endometrium and spesific binding to cytosol receptor. Am.J.Obs.Gyn.132:549(1979).

- (4).Sherman A.I.Browns:The precursors of endometrial carcinoma Am.J.Obs.Gyn.135:947(1979).

- (5).Wentz WB:Progestins therapy in endometrial hyperplasia.Gyn.onc.2:362(1974) 12-(12).Wentz WB:Treatment of persistent endometrial hyperplasia with progestins. Am.J. Obs.Gyn. 96:999(1966).

Downloads

Published

1992-06-01

How to Cite

SAYGILI, H., HAS, R., & YILDIRIM, A. (1992). Treated With Gestajen in Endometrial Hyperplazi: [Endometrial Hyperplazi’de Gestagen Tedavisi]. European Journal of Therapeutics, 3(2), 180–184. https://doi.org/10.58600/eurjther.19920302-1067

Issue

Section

Original Articles